The Economics of Multiple Sclerosis: Distribution of Costs and Relationship to Disease Severity

Author： Grudzinski A.N.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.15, Iss.3, 1999-03, pp. : 229-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The forgotten costs of multiple sclerosis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 347, 2002-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Health-Related Quality of Life in Multiple Sclerosis: Current Evidence, Measurement and Effects of Disease Severity and Treatment

By Rudick Richard A.   Miller Deborah M.  

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 827-839

Adis International

Access to resources Recommend Favorite

COPD costs depend on disease severity, drug therapy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 297, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Improve treatment of multiple sclerosis by defining specific pain syndromes and analysing their relationship to the disease

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 1, 2009-01 ,pp. : 14-17

Adis International

Access to resources Recommend Favorite

The long and evolving relationship between viruses and multiple sclerosis

By Delbue Serena   Carluccio Silvia   Ferrante Pasquale  

Future Virology, Vol. 7, Iss. 9, 2012-09 ,pp. : 871-883

Future Medicine

Access to resources Recommend Favorite